Norito Yoshimura

Suggest Changes
Learn More
OBJECTIVE Although peroxisome proliferator-activated receptor (PPAR) δ agonists have been shown to improve the serum lipoprotein profiles in humans, the impact of the changes in these lipoprotein(More)
  • 1